Examination GuideHong KongInventionsPatent LawUpdates and Changes
2024年2月29日

Updates on Hong Kong Patents Examination Guidelines in 2024

The Intellectual Property Department of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China (HKIPD) has recently made several updates to the Hong Kong Patents Examination Guidelines, effective from 26 January, 2024. These changes mainly clarify and reflect the Registry’s current practices regarding patent examination for Standard Patent (R) Applications, Standard Patent (O) Applications (i.e., Original Grant Patents (OGP)), and Short-Term Patent Applications. We briefly summarize the key revisions below:

Section 1: Novelty - This section only made a minor textual revision to correct a typographical error to refer to the correct section (from section 1.61 to 1.62) in 1.61. The change made is not substantial.

Section 4: Exclusions from Patentability: Excluded Subject Matter - The revisions in Section 4.7 clarify that art falling within the field of section 9B(3)1 of the Ordinance will not be excluded for consideration when assessing the contribution that an inventor has added to human knowledge in the second step of the Aerotel/Macrossan test2. In other words, all art falling within the definition of “state of the art” under 9B(3) shall be included within the scope of “human knowledge”.

Section 7: Kinds of Claims - The amendments made to Section 7.6 aim to clarify the examples of claims that are not necessarily dependent claims in substance. In brief, the amendments clarify that (1) a claim referring to another claim of a different category (e.g., an apparatus for carrying out the process of claim 1); and (2) a claim to one part referring to another co-operating part of another claim (e.g., a plug for co-operation with the socket of claim 1) are not necessarily dependent claims in substance. In other words, they are considered independent claims.

Section 13: Patent Applications - The revised guidelines in section 13.24(b) clarify the examination standards of the statement of entitlement to apply. In brief, an updated official register of the designated patent office or an official communication from the designated patent office confirming a transfer, assignment or mortgage will no longer be recognized as a supporting document that can establish an applicant’s entitlement to apply for a request for registration and grant of a Standard Patent (R) if the applicant for the request for registration and grant is not the same as the entity named in the register (i.e., the applicant for request to record). The applicant will need to submit a copy of the duly executed transfer, assignment or mortgage agreement.

Section 15: Substantive Examination of Standard Patent (O) Applications and Short-term Patents - This section has undergone significant changes to provide further clarity and guidance on the role of hearings as part of the patent prosecution process. In brief, for a Standard Patent (O) and Short-Term application, if the Registrar issues a review opinion and/or a further review opinion(s) to the applicant, the Registrar will generally offer the applicant an opportunity to file a request for a hearing if the Registrar thinks it fit to do so. In addition, before a Standard Patent (O) application is refused (section 15.29A) or a Short-Term patent is revoked (section 15.50A), the applicant or the proprietor must be given an opportunity to be heard. In other words, OGP and Hong Kong Short-Term applicants generally will have an opportunity to conduct a hearing in response to a review opinion and/or further review opinion(s), especially before an application is finally rejected/revoked.

EIP Thoughts

Since its launch in December 2019, the Standard Patent (O) (i.e., OGP system) has enriched the patent landscape in Hong Kong. This system allows applicants to directly file patent applications in Hong Kong without the need for a prior granted patent from China, Europe, or the UK. As we enter the fifth year of its implementation, a significant number of initial applications have now reached the substantive examination stage. We believe that the HKIPD has recognized the need for clarification of certain aspects of the Patents Examination Guidelines to ensure consistency with the latest practices and examination procedures. For further details and the complete revised guidelines, please refer to the Hong Kong Intellectual Property Department's official website.

We hope this information proves useful and assists you in navigating the Hong Kong patent examination processes effectively. As always, we remain dedicated to providing Hong Kong patent law updates.

If you would like to have more information on this matter or would like to have our advice, please feel free to contact us at [email protected].

This article is for general informational purposes only and should not be considered legal advice or a legal opinion on a specific set of facts.

About the Authors

Bill Yip is a qualified Chinese Patent Attorney at Eagle IP, a Boutique Patent Firm with offices in Hong Kong, Shenzhen, and Macau.

Jennifer Che, J.D. is Managing Director and a US Patent Attorney at Eagle IP, a Boutique Patent Firm with offices in Hong Kong, Shenzhen, and Macau.

其他文章

Beijing IP Court Reverses CNIPA Decision and Upholds Ozempic® semaglutide patent in China as VALID based on Novo Nordisk’s Post Filing Data

2024年6月27日
Recently, all eyes have been on China as the fundamental patent covering semaglutide, the active ingredient in Ozempic® and Wegovy®, will expire on March 20, 2026. It goes without saying that generics are ramping up bigtime in China (and also around the world), preparing to manufacture and sell this blockbuster drug to one of the […]

New Policies to Promote Importation of Innovative Drugs

2018年11月8日
At the April 12, 2018 executive meeting of the State Council in China, Premier Mr. Li Keqiang indicated the government’s desire to increase China’s access to innovative drugs. To achieve this, the government would encourage importation of innovative drugs into China by streamlining the regulatory pathway, enhancing IP protection, and lowering the cost of medicine. […]

Can Post Filing Data Overcome Inventive Step in China?

2018年11月19日
Since 2010, the Patent Re-examination Board (PRB) has published the top 10 patent invalidation cases of the year in April of each year. The selection criteria are high social concern, significant impact on the related industry, or involve difficult legal issues and important examination criteria. Below is one of the top 10 cases that discusses […]

Stealing Trade Secrets: How the Chinese Court Criminally Sentences Employees that Steal Trade Secrets - 2019 China’s Top 50 Representative IP Cases

2020年6月11日
The theft of trade secrets has always been a deep concern of foreign companies thinking of doing business in China, whether it be sharing protocols with a manufacturing partner, providing technology details to a potential investor, or sharing results from an R&D collaboration. How can businesses ensure that employees do not steal secrets and share […]

我们的过去活动

Top crossarrow-right